Analystreport

Adaptive Biotechnologies (NASDAQ:ADPT) had its price target raised by analysts at JPMorgan Chase & Co. from $14.00 to $17.00. They now have an "overweight" rating on the stock.

Adaptive Biotechnologies Corporation  (ADPT) 
Last adaptive biotechnologies corporation earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: adhc.com